Enrolments for this course have closed. This course has been reviewed and it has been determined that it should be discontinued as the content is not current. Your completion certificates will continue to be available.
This activity allows you to screen patients at risk of CKD and identify those with early signs of the disease.
Enrolments for this course have closed. This course has been reviewed and it has been determined that it should be discontinued as the content is not current. Your completion certificates will continue to be available.
This activity allows you to review your approach to the diagnosis and the management of CKD.
Enrolments for this course have closed. This course has been reviewed and it has been determined that it should be discontinued as the content is not current. Your completion certificates will continue to be available.
This activity allows you to optimise your prescribing for CKD, including the use of:
- angiotensin-converting enzyme (ACE) inhibitors / angiotensin II receptor blockers (ARBs) and
- sodium-glucose co-transporter-2 (SGLT2) inhibitors to treat those with CKD and type 2 diabetes.
Enrolments for this course have closed. This course has been reviewed and it has been determined that it should be discontinued as the content is not current. Your completion certificates will continue to be available.
Enrolments for this course have closed. This course has been reviewed and it has been determined that it should be discontinued as the content is not current. Your completion certificates will continue to be available.
Enrolments for this course have closed. This course has been reviewed and it has been determined that it should be discontinued as the content is not current. Your completion certificates will continue to be available.
